Amit Hazan
Stock Analyst at Goldman Sachs
(2.62)
# 1,309
Out of 4,416 analysts
86
Total ratings
53.85%
Success rate
0.18%
Average return
Main Sectors:
24 Stocks
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
INSP Inspire Medical Systems | Upgrades: Buy | n/a | $245.63 | - | 2 | Dec 13, 2022 | |
BVS Bioventus | Maintains: Neutral | $13 → $2.5 | $5.12 | -51.17% | 5 | Nov 30, 2022 | |
SKIN The Beauty Health Company | Maintains: Buy | $22 → $19 | $3.37 | +463.80% | 4 | Nov 23, 2022 | |
SHC Sotera Health Company | Maintains: Neutral | $9 → $8 | $11.47 | -30.25% | 4 | Nov 23, 2022 | |
LIVN LivaNova | Maintains: Buy | $73 → $63 | $63.12 | -0.19% | 3 | Nov 23, 2022 | |
BDX Becton, Dickinson and Company | Maintains: Buy | $319 → $272 | $237.15 | +14.70% | 7 | Nov 23, 2022 | |
BLCO Bausch + Lomb | Maintains: Neutral | $19 → $17 | $14.90 | +14.09% | 3 | Nov 23, 2022 | |
AGTI Agiliti | Maintains: Buy | $23 → $20 | $10.05 | +99.00% | 4 | Nov 14, 2022 | |
OM Outset Medical | Maintains: Buy | $34 → $29 | $3.79 | +665.17% | 2 | Nov 9, 2022 | |
PRCT PROCEPT BioRobotics | Maintains: Neutral | $39 → $44 | $62.79 | -29.93% | 2 | Nov 4, 2022 | |
EW Edwards Lifesciences | Maintains: Neutral | $97 → $73 | $85.84 | -14.96% | 2 | Nov 3, 2022 | |
BAX Baxter International | Maintains: Sell | $60 → $53 | $36.12 | +46.73% | 10 | Nov 3, 2022 | |
ENOV Enovis | Initiates: Buy | $57 | $52.24 | +9.11% | 1 | Oct 11, 2022 | |
AFIB Acutus Medical | Maintains: Neutral | $1 → $1.5 | $0.12 | +1,119.51% | 3 | Aug 16, 2022 | |
ATEC Alphatec Holdings | Maintains: Neutral | $11 → $9.5 | $13.58 | -30.04% | 2 | Aug 8, 2022 | |
ABT Abbott Laboratories | Maintains: Sell | $111 → $104 | $106.17 | -2.04% | 7 | Jul 25, 2022 | |
TXG 10x Genomics | Maintains: Neutral | $80 → $60 | $26.14 | +129.53% | 2 | Jul 14, 2022 | |
MDT Medtronic | Maintains: Neutral | $129 → $115 | $81.90 | +40.42% | 5 | Jan 18, 2022 | |
SYK Stryker | Downgrades: Sell | n/a | $332.14 | - | 2 | Apr 1, 2020 | |
BSX Boston Scientific | Initiates: Neutral | n/a | $73.43 | - | 1 | Feb 13, 2020 | |
ISRG Intuitive Surgical | Initiates: Buy | n/a | $388.65 | - | 6 | Feb 13, 2020 | |
ZBH Zimmer Biomet Holdings | Initiates: Buy | n/a | $121.43 | - | 2 | Feb 13, 2020 | |
JNJ Johnson & Johnson | Maintains: Neutral | n/a | $148.72 | - | 6 | Feb 25, 2019 | |
ARAY Accuray | Upgrades: Neutral | n/a | $1.75 | - | 1 | Nov 1, 2018 |
Inspire Medical Systems
Dec 13, 2022
Upgrades: Buy
Price Target: n/a
Current: $245.63
Upside: -
Bioventus
Nov 30, 2022
Maintains: Neutral
Price Target: $13 → $2.5
Current: $5.12
Upside: -51.17%
The Beauty Health Company
Nov 23, 2022
Maintains: Buy
Price Target: $22 → $19
Current: $3.37
Upside: +463.80%
Sotera Health Company
Nov 23, 2022
Maintains: Neutral
Price Target: $9 → $8
Current: $11.47
Upside: -30.25%
LivaNova
Nov 23, 2022
Maintains: Buy
Price Target: $73 → $63
Current: $63.12
Upside: -0.19%
Becton, Dickinson and Company
Nov 23, 2022
Maintains: Buy
Price Target: $319 → $272
Current: $237.15
Upside: +14.70%
Bausch + Lomb
Nov 23, 2022
Maintains: Neutral
Price Target: $19 → $17
Current: $14.90
Upside: +14.09%
Agiliti
Nov 14, 2022
Maintains: Buy
Price Target: $23 → $20
Current: $10.05
Upside: +99.00%
Outset Medical
Nov 9, 2022
Maintains: Buy
Price Target: $34 → $29
Current: $3.79
Upside: +665.17%
PROCEPT BioRobotics
Nov 4, 2022
Maintains: Neutral
Price Target: $39 → $44
Current: $62.79
Upside: -29.93%
Edwards Lifesciences
Nov 3, 2022
Maintains: Neutral
Price Target: $97 → $73
Current: $85.84
Upside: -14.96%
Baxter International
Nov 3, 2022
Maintains: Sell
Price Target: $60 → $53
Current: $36.12
Upside: +46.73%
Enovis
Oct 11, 2022
Initiates: Buy
Price Target: $57
Current: $52.24
Upside: +9.11%
Acutus Medical
Aug 16, 2022
Maintains: Neutral
Price Target: $1 → $1.5
Current: $0.12
Upside: +1,119.51%
Alphatec Holdings
Aug 8, 2022
Maintains: Neutral
Price Target: $11 → $9.5
Current: $13.58
Upside: -30.04%
Abbott Laboratories
Jul 25, 2022
Maintains: Sell
Price Target: $111 → $104
Current: $106.17
Upside: -2.04%
10x Genomics
Jul 14, 2022
Maintains: Neutral
Price Target: $80 → $60
Current: $26.14
Upside: +129.53%
Medtronic
Jan 18, 2022
Maintains: Neutral
Price Target: $129 → $115
Current: $81.90
Upside: +40.42%
Stryker
Apr 1, 2020
Downgrades: Sell
Price Target: n/a
Current: $332.14
Upside: -
Boston Scientific
Feb 13, 2020
Initiates: Neutral
Price Target: n/a
Current: $73.43
Upside: -
Intuitive Surgical
Feb 13, 2020
Initiates: Buy
Price Target: n/a
Current: $388.65
Upside: -
Zimmer Biomet Holdings
Feb 13, 2020
Initiates: Buy
Price Target: n/a
Current: $121.43
Upside: -
Johnson & Johnson
Feb 25, 2019
Maintains: Neutral
Price Target: n/a
Current: $148.72
Upside: -
Accuray
Nov 1, 2018
Upgrades: Neutral
Price Target: n/a
Current: $1.75
Upside: -